Satya to present the preclinical profile of first-in-class RAD51 inhibitors at the Upcoming ESMO Congress – Oct 20-24, Madrid, Spain
Abstract title SAT-122, a potential first-in-class, potent, small-molecule disruptor of RAD51-BRCA2, attenuates RAD51 foci formation and tumor progression in preclinical models Poster number FPN: 35P Publication category Basic science Session date and time Sunday, October 22 | 9:00 am-5:00 pm Session location Hall 8 Abstract title: SAT-122, a potential first-in-class, potent, small-molecule disruptor of RAD51-BRCA2, […]
